Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses

被引:0
作者
Xin Pan
Wei Liu
Yi Chai
Libo Hu
Junhua Wang
Yuqi Zhang
机构
[1] Tsinghua University,Department of Neurosurgery, Yuquan Hospital, School of Clinical Medicine
[2] Tsinghua University,School of Clinical Medicine
来源
Journal of Molecular Neuroscience | 2020年 / 70卷
关键词
Atypical teratoid/rhabdoid tumor; Bioinformatics analyses; Differentially expressed genes; Therapeutic target;
D O I
暂无
中图分类号
学科分类号
摘要
Atypical teratoid/rhabdoid tumor (ATRT) is a devastating intracranial tumor in children. Currently, its molecular mechanisms cannot be studied effectively because patient samples are limited, and many factors are involved in its pathogenesis. In this study, we analyzed three gene expression profile data sets obtained from the Gene Expression Omnibus (GEO) database to identify genes that participate in ATRT. The datasets were integrated and analyzed using the RobustRankAggreg method to screen for differentially expressed genes (DEGs). We identified 197 DEGs, including 94 downregulated and 103 upregulated genes which were then used for gene set enrichment analysis. The results showed that the downregulated genes were mainly enriched in synaptic vesicle cycle, nicotine addiction, and GABAergic synapse, whereas the upregulated genes were enriched in the cell cycle, p53 signaling pathway, and cellular senescence. Consistent with these results, gene set enrichment analysis showed that E2F targets, G2M checkpoints, and MYC targets were significantly enriched in datasets. Protein-protein interaction (PPI) network revealed that CDK1, CCNA2, BUB1B, CDC20, KIF11, KIF20A, KIF2C, NCAPG, NDC80, NUSAP1, PBK, RRM2, TPX2, TOP2A, and TTK were hub genes. NetworkAnalyst algorithm was used to predict the transcription factor (TF), and the results showed that MYC, SOX2, and KDM5B could regulate these hub genes. In conclusion, the present study brings a new perspective of ATRT pathogenesis and the strategy targeted to cell cycle related gene may be promising treatments for the disease.
引用
收藏
页码:1906 / 1913
页数:7
相关论文
共 84 条
[1]  
Brooks TA(2009)The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics Nat Rev Cancer 9 849-861
[2]  
Hurley LH(2017)Integrated genomic characterization of oesophageal carcinoma Nature 541 169-175
[3]  
Chen W(2014)MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells J Neuro-Oncol 120 43-53
[4]  
Cole MD(2008)Transcription-independent functions of MYC: regulation of translation and DNA replication Nat Rev Mol Cell Biol 9 810-815
[5]  
Cowling VH(2016)Positive expression of KIF20A indicates poor prognosis of glioma patients OncoTargets and therapy 9 6741-6749
[6]  
Duan J(2020)E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2 J Cell Mol Med 24 2157-2168
[7]  
Huang W(2016)Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies Neuro-Oncology 18 764-778
[8]  
Shi H(2018)Identification of key candidate genes and biological pathways in bladder cancer PeerJ 6 e6036-725
[9]  
Feng Y(2017)JARID1 histone Demethylases: emerging targets in cancer Trends Cancer 3 713-1930
[10]  
Li L(2019)Transcriptional regulation of G2/M regulatory proteins and perturbation of G2/M cell cycle transition by a traditional Chinese medicine recipe J Ethnopharmacol 251 112526-362